Article Information
History
- December 16, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Kirsty McCance1,*,
- Helen Wise1,
- Jennifer Simpson1,
- Becky Bachelor2,
- Harriet Hale2,
- Lindsay McDonald1,
- Azul Zorzoli1,
- Elizabeth Furrie3,
- Charu Chopra4,
- Frauke Muecksch5,
- Theodora Hatziioannou5,
- Paul D. Bieniasz5,6,
- Kate Templeton1 and
- Sara Jenks1
- 1Department of Biochemistry, Royal Infirmary of Edinburgh, NHS Lothian, Edinburgh, Scotland
- 2Western General Hospital, NHS Lothian, Edinburgh
- 3Ninewells Hospital and Medical School, NHS Tayside, Dundee, Scotland
- 4Department of Immunology, Royal Infirmary of Edinburgh, NHS Lothian
- 5Laboratory of Retrovirology, The Rockefeller University, New York, New York, USA
- 6Howard Hughes Medical Institute, The Rockefeller University, New York, New York, USA
- ↵*corresponding author: kirsty.mccance{at}nhslothian.scot.nhs.uk
Contributions: SJ, KT, CC, BB and HW came up with the study idea. HW and AZ collated company details and manufacturer info. KM and SJ assisted with study visits. HW, KM, JS and LM carried out evaluation of the POC devices in the laboratory. KM, SJ, and EF carried out capillary POC testing. FM, TH and PB carried out neutralising antibody assays. HW, KM, JS and SJ carried out data analysis and wrote the first draft of the manuscript. All authors reviewed the manuscript.